| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |